New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019

Technologically advanced qPCR and digital PCR (dPCR) products offer a promising future which is showcasing high growth opportunities for market players.

(PRWEB) March 06, 2015

The global digital PCR (dPCR) and qPCR market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.

The global digital PCR (dPCR) and qPCR market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Although the mature markets such as the U.S., Germany, France and U.K.) hold larger shares in the digital PCR (dPCR) and qPCR market the Asia-Pacific region is expected to grow at the highest CAGR of 10.7% in the forecast period. The growth of the digital PCR (dPCR) and qPCR market is driven by factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases and genetic disorders, and increased public-private investments, funds and grants. However factors such as high cost of dPCR instruments and limitations of qPCR and dPCR techniques are restraining the growth of this market. Attempts for adoption, implementation of MIQE guidelines for publishing qPCR and dPCR-based research is posing a significant challenge for the growth of the digital PCR (dPCR) and qPCR market.

Get Complete Report @ http://www.marketsandmarkets.com/Market-Reports/digital-prc-qprc-market-174151204.html

In this report the global digital PCR (dPCR) and qPCR market has been segmented on the basis of type of technology (real-time PCR and digital PCR), type of product (instruments, reagents and consumables, and softwares and services), type of end-users (research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories) applications and type of application (research, clinical, and forensic applications). The real-time PCR (qPCR) technology market accounted for the largest share of the global digital PCR (dPCR) and qPCR market in 2014, followed by the digital PCR (dPCR) market. Factors such as technological advancements in the field of qPCR, rising adoption of qPCR in research and medical diagnosis, benefits offered by robotics in lab automation, and increasing installation base of qPCR instruments are driving the growth of qPCR technology market.

Speak with Research Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=174151204

Geographically North America comprising the U.S. and Canada commands the largest share of 39.7% of the global digital PCR (dPCR) and qPCR market in 2014, followed by Europe. The digital PCR (dPCR) and qPCR market in North America is primarily driven by factors such as increase in public and private funding for development of qPCR and dPCR technology, growing number of cancer patients, continuous reduction in average cost of gene sequencing, and presence of major pharmaceutical companies in the U.S. However financial constraints faced by market players are limiting the growth of the digital PCR (dPCR) and qPCR market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 10.7% in the next five years owing to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market, and strengthening cancer research in Japan.

Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), BioMerieux SA (France), Takara Bio (Japan), RainDance Technologies, Inc. (U.S.), Eppendorf AG (Germany), and BioSistemika Research and Development LLC (Slovenia) are the key players operating in the global digital PCR (dPCR) and qPCR market.

About MarketsandMarkets
MarketsandMarkets is the world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full time analysts and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, and identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

For the original version on PRWeb visit: http://www.prweb.com/releases/digital-prc/market/prweb12516812.htm